儿童炎症性肠病患者严重急性呼吸综合征冠状病毒2感染的良性演变:来自两个国际数据库的结果
本文描述了两个国际数据库中扩展样本的儿童炎症性肠病(IBD)患者COVID-19的疾病过程。基于SARSCoV2通过血管紧张素转换酶2受体进入细胞且该受体在回肠末端和结肠高表达,需纵向数据评估IBD患者是否有重症COVID-19风险;近期SECURE-IBD登记分析显示高龄、激素用药和合并症是严重演变的风险因素,且29例20岁以下IBD患者仅表现为轻度病程。
要点
- 儿童IBD患者COVID-19可能呈良性病程,扩展样本来自两个国际数据库。
- SECURE-IBD登记分析中29例20岁以下IBD患者仅表现为轻度病程。
- 高龄、激素用药和合并症是IBD患者COVID-19严重演变的风险因素。
核心结论
- 本文描述了两个国际数据库中扩展样本的儿童IBD患者COVID-19的疾病过程。
研究设计与样本
- 基于两个国际数据库的儿童IBD患者COVID-19疾病过程描述。
主要发现
- 近期SECURE-IBD登记分析显示高龄、激素用药和合并症是严重演变的风险因素。
- 该分析中29例20岁以下IBD患者仅表现为轻度病程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The coronavirus disease 2019 (COVID-19) pandemic caused by the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents most often with mild clinical symptoms, but the severe forms are of major concern.1 SARS-CoV-2 enters human cells via the angiotensin-converting enzyme 2 receptor, expressed on epithelial and endothelial cells.2 Because the highest angiotensin-converting enzyme 2 expression is in the terminal ileum and colon, and up-regulated further during inflammation, and many COVID-19 patients experience gastrointestinal symptoms, longitudinal data are necessary to determine whether inflammatory bowel disease (IBD) patients are at risk for severe or complicated COVID-19. A recent analysis in IBD patients from the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) registry showed older age, steroid medication, and comorbidities as risk factors for severe evolution, and the same study showed that the 29 IBD patients younger than age 20 had only mild disease courses.3 This report describes the disease course of COVID-19 in an expanded sample of pediatric IBD patients from 2 international databases.
引用
- Brenner EJ, Pigneur B, Focht G, et al. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clin Gastroenterol Hepatol. 2020. PMID: 33059040. doi:10.1016/j.cgh.2020.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。